These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1977490)

  • 41. The clinical efficacy of sulphasalazine in rheumatic disease.
    Taggart AJ
    Agents Actions Suppl; 1988; 24():189-96. PubMed ID: 2903619
    [No Abstract]   [Full Text] [Related]  

  • 42. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulphasalazine: a 'new' antirheumatic drug.
    Pullar T; Capell HA
    Br J Rheumatol; 1984 Feb; 23(1):26-34. PubMed ID: 6141832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 47. Sulphasalazine in the long term management of rheumatoid arthritis.
    Bax DE; Amos RS
    Drugs; 1986; 32 Suppl 1():73-6. PubMed ID: 2877858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
    Greaves M; Amos RS; Bax D
    Br Med J (Clin Res Ed); 1987 Feb; 294(6568):373. PubMed ID: 2880620
    [No Abstract]   [Full Text] [Related]  

  • 49. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
    Delamere JP; Farr M; Grindulis KA
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
    [No Abstract]   [Full Text] [Related]  

  • 50. Sulphasalazine desensitisation in rheumatoid arthritis.
    Farr M; Scott DL; Bacon PA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):118. PubMed ID: 6119134
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
    Situnayake RD; Grindulis KA; McConkey B
    Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulphasalazine treatment in rheumatoid arthritis.
    Winkler V; Vértes P
    Ann Rheum Dis; 1990 Mar; 49(3):202. PubMed ID: 1969729
    [No Abstract]   [Full Text] [Related]  

  • 54. Fatal agranulocytosis with sulfasalazine therapy in rheumatoid arthritis.
    Canvin JM; el-Gabalawy HS; Chalmers IM
    J Rheumatol; 1993 May; 20(5):909-10. PubMed ID: 8101571
    [No Abstract]   [Full Text] [Related]  

  • 55. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Laversuch CJ; Collins DA; Charles PJ; Bourke BE
    Br J Rheumatol; 1995 May; 34(5):435-9. PubMed ID: 7788172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute alveolitis and sulphasalazine in rheumatoid arthritis.
    Geborek P; Monti M; Sandblad F; Wollheim FA
    Clin Exp Rheumatol; 1984; 2(3):279-80. PubMed ID: 6152205
    [No Abstract]   [Full Text] [Related]  

  • 59. Sulphasalazine in rheumatoid arthritis.
    Bax DE; Amos RS; Situnayake D; McConkey B
    Lancet; 1985 Jun; 1(8443):1450. PubMed ID: 2861393
    [No Abstract]   [Full Text] [Related]  

  • 60. Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.
    Shovman O; Shoenfeld Y; Langevitz P
    Immunol Res; 2015 Feb; 61(1-2):164-8. PubMed ID: 25403696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.